Novartis AG
Bis 2'-5'-RR-(3'F-A)(3'F-A) cyclic dinucleotide compound and uses thereof

Last updated:

Abstract:

The present invention provides the cyclic dinucleotide compound 2'2'-RR-(3'F-A)(3'F-A) as a highly active immune stimulator that activates DCs via the cytoplasmic receptor known as STING (Stimulator of Interferon Genes), and compositions and uses thereof.

Status:
Grant
Type:

Utility

Filling date:

26 Apr 2018

Issue date:

13 Apr 2021